FLT3LG and neoplasm: ELISA assays demonstrated that both Flt3L and OX40L concentrations in tumors and tumor‐draining lymph nodes (TDLN) increased rapidly, peaked on Day 7, and declined by Days 10 and 15 (Figure8a,b).